DILLAN SOLANKI: Open Payments
NPI 1851022537 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 10 payments from 4 companies in 2025. Trend: 2023 $56 · 2024 $133 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| Bioventus LLC | 4 | $193 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $58 |
| Pacira Pharmaceuticals Incorporated | 2 | $44 |
| Fidia Pharma USA Inc. | 1 | $16 |
Products named: DUROLANE, EXOGEN ULTRASOUND BONE HEALING SYSTEM, JOURNAVX, XCELL, Exparel, Iovera, HYMOVIS.
Industry payments across NC — which companies pay providers there.
